NCT04721301 2023-10-17
Ipilimumab, Maraviroc and Nivolumab in Advanced Metastatic Colorectal and Pancreatic Cancer the LUMINESCENCE Trial
University Hospital Heidelberg
Phase 1 Completed
Clinical Trials
5 trialsNCT03274804 2022-06-07
PICCASSO
University Hospital Heidelberg
Phase 1 Completed
NCT01276236 2021-03-05
Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS)
University of California, San Francisco
Phase 2 Completed
NCT01785810 2021-01-11
Phase II Maraviroc for GVHD Prevention
Abramson Cancer Center at Penn Medicine
Phase 2 Completed
NCT02208037 2019-01-23
Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)
National Heart, Lung, and Blood Institute (NHLBI)
Phase 2 Completed